A quantitative analysis of lymphatic vessels in human breast cancer, based on LYVE-1 immunoreactivity

British Journal of Cancer

Volumn 93, Issue 10, 2005, Pages 1168-1174

  Kato, T ^a,b,d   Prevo, R ^c   Steers, G ^b   Roberts, H ^b   Leek, R D ^b   Kimura, T ^a   Kameoka, S ^a   Nishikawa, T ^a   Kobayashi, M ^a   Jackson, D G ^c   Harris, A L ^c   Gatter, K C ^b   Pezzella, F ^b  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^d Onuma Hospital   (Japan)

Author keywords

Breast cancer; Lymphangiogenesis; Lymphatic microvessel density; Lymphatic tumour dissemination; Lymphatic vessel invasion; LYVE 1

Indexed keywords

LYMPHATIC VESSEL ENDOTHELIAL HYALURONAN RECEPTOR I; MONOCLONAL ANTIBODY; PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INVASION; CANCER SURVIVAL; CONNECTIVE TISSUE; ERYTHROCYTE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; LYMPH VESSEL; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; STAINING; TUMOR DIAGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC VESSELS; MIDDLE AGED;

EID: 27944491602     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6602844     Document Type: Article

References (42)

1. Abtahian F, Guerriero A, Lu M-M, Zhou R, Mocsai A, Myers EE, Huang B, Jackson DG, Ferrari VA, Tybulewicz V, Lowell CA, Lepore JJ, Koretzky GA, Kahn ML (2003) Separation of blood and lymphatic vascular networks is regulated by the haematopoietic signalling proteins SLP-76 and SYK. Science 299: 247-251
2. Banerji S, Ni J, Wang SX, Clasper S, Su J, Tammi R, Jones M, Jackson DG (1999) LIVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol 144: 789-801
3. Beasley NJP, Prevo R, Banerji S, Leek R, Moore J, von Trappen P, Cox G, Harris AL, Jackson DG (2002) Lymphangiogenesis is linked to tumour metastasis in head and neck cancer. Cancer Res 62: 1315-1320
4. Birner P, Schindl M, Obermair A, Breitenecker G, Kowalski H, Oberhuber G (2001) Lymphatic microvessel density as a novel prognostic factor in early-stage invasive cervical cancer. Int J Cancer 95: 29-33
5. Bono P, Wasenius V-M, Lundin J, Jackson DG, Joensuu H (2004) High LYVE-1 positive lymphatic vessel numbers are associated with poor outcome in breast cancer. Clin Cancer Res 10: 7144-7149
6. Breiteneder - Geleff S, Matsuki K, Soleiman A, Meraner P, Poczewski H, Kalt R, Schaffner G, Kerjaschki D (1997) Podoplanin novel 43-kd membrane protein of glomerular epithelial cells, is down-regulated in puromycin nephrosis. Am J Pathol 151: 1141-1152
7. Cao R, Bjorndahl M, Religa P, Garvin S, Galter D, Clasper S, Meister B, Ikomi F, Hansen AJ, Dissing S, Ohhashi T, Jackson DG, Cao Y (2004) PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis. Cancer Cell 6: 205-226
8. Choi WWL, Lewis MM, Lawson D, Yin-Goen Q, Birdsong GG, Cotsonis GA, Cohen C, Young AN (2005) Angiogenic and lymphangiogenic microvessel density in breast carcinoma: correlation with clinicopathologic parameters and VEGF-family gene expression. Modern Pathol 18:143-152
9. Clarijs R, Ruiter DJ, de Waal RM (2001) Lymphangiogenesis in malignant tumours: does it occur? J Pathol 193: 143-146
10. Cursiefen C, Schlotzer-Schrehardt U, Kuchle M, Sorokin L, Breiteneder-Geleff S, Alitalo K, Jackson D (2002) Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and podoplanin. Invest Ophthalmol Vis Sci 43: 2127-2135
11. Dadras S, Paul T, Bertoncini J, Brown LF, Muzikansky A, Jackson DG, Ellwanger U, Garbe C, Mihm MC, Detmar M (2003) Tumor lymphangiogenesis: A novel prognostic indicator for cutaneous melanoma metastasis and survival. Am J Pathol 162: 1951-1960
12. Fisher B, Fisher ER (1966) The inter-relationship of hematogenous and lymphatic tumour cell dissemination. Surg Gynecol Obstet 122: 791-798
13. Fox SB, Leek RD, Weekes MP, Whitehouse RM, Gatter KG, Harris A (1995) Quantitation and prognostic value of breast cancer angiogenesis: Comparison of microvessel density, Chalkley count, and computer image analysis. J Pathol 177: 275-283
14. Gunningham S, Currie J, Han C, Robinson BA, Scott PAE, Harris AL, Fox SB (2000) The short form of the alternatively spliced flt-4 but not its ligand vascular endothelial growth factor C is related to lymph node metastasis in human breast cancer. Clin Cancer Res 6: 4278-4286
15. Hall FT, Freeman JL, Asa SL, Jackson DG, Beasley NJ (2003) Intratumoral lymphatics and lymph node metastases in papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg 129: 716-719
16. Hartveit F (1990) Attenuated cells in breast stroma: the missing lymphatic system of the breast. Histopathology 16: 533-543
17. Horak ER, Leek R, Klenk N, Lejeune S, Smith K, Stuart N, Greenall M, Stepniewska K, Harris A (1992) Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 340: 1120-1124
18. Jackson DG (2001) New Markers for the study of Lymphangiogenesis. Anticancer Res 21: 4279-4283
19. Jackson DG (2003) The Lymphatics revisited: New perspectives from the hyaluronan receptor LYVE-1. Trends Cardiovasc Med 13: 1-7
20. Jackson DG (2004) Biology of the lymphatic marker LYVE-1 and applications in research into lymphatic trafficking and lymphangiogenesis. APMIS 112: 526-538
21. Kahn HJ, Bailey D, Marks A (2002) Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas. Mod Pathol 15: 434-440
22. Kaplan EL, Meier P (1958) Non-parametric estimation from incomplete observations. J AmStat Assoc 53: 457-481
23. Kato T, Kameoka S, Kimura T, Nishikawa T, Kobayashi M (2002) Blood vessel invasion as a predictor of long-term survival for Japanese patients with breast cancer. Breast Cancer Res Treat 73: 1-12
24. Kato T, Kameoka S, Kimura T, Nishikawa T, Kobayashi M (2003) The combination of angiogenesis and blood vessel invasion as a prognostic indicator in primary breast cancer. Br J Cancer 88: 1900-1908
25. Kato T, Kameoka S, Kimura T, Soga N, Abe Y, Nishikawa T, Kobayashi M (2001) Angiogenesis as a predictor of long-term survival for 377 Japanese patients with breast cancer. Breast Cancer Res Treat 70: 65-74
26. Kinoshita J, Kitamura K, Kabashima A, Saeki H, Tanaka S, Sugimachi K (2001) Clinical significance of vascular endothelial growth factor-C (VEGF-C) in breast cancer. Breast Cancer Res Treat 66: 159-164
27. Kukk E, Lymboussaki A, Taira S, Kaipainen A, Jeltsch M, Joukov V, Alitalo K (1996) VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. Development 122: 3829-3837
28. Leu AJ, Berk DA, Lymboussaki A, Alitalo K, Jain RK (2000) Absence of functional lymphatics within a murine sarcoma: a molecular and functional evaluation. Cancer Res 60: 4324-4327
29. Lymboussaki A, Olofsson B, Eriksson U, Alitalo K (1999) Vascular endothelial growth factor (VEGF) and VEGF-C show overlapping binding sites in embryonic endothelia and distinct sites in differentiated adult endothelioma. Cir Res 85: 992-999
30. Mandriota SJ, Jussila L, Jeltsch M, Compagni A, Baetens D, Prevo R, Banerji S, Huarte J, Montesano R, Jackson DG, Orci L, Alitalo K, Christofori G, Pepper MS (2001) Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J 20: 672-682
31. Maula SM, Luukkaa M, Grenman R, Jackson D, Jalkanen S, Ristamaki R (2003) Intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinomas of the head and neck region. Cancer Res 63: 1920-1926
32. Nathanson SD, Zarbo RJ, Wachna DL, Spence CA, Andrzejewski TA, Abrams J (2000) Microvessels that predict axillary lymph node metastases in patients with breast cancer. Arch Surg 135: 584-593
33. Padera TP, Yun C, Kadambi A, Mouta Carreira C, Jain RK (2000) Local mechanism and VEGF-C alter peri-tumor lymphatic function. Proc Am Assoc Cancer Res 41: 88
34. Schoppmann SF, Bayer G, Aumayr K, Taucher S, Geleff S, Rudas M, Kubista E, Hausmaninger H, Samonigg H, Gnant M, Jakesz R, Horvat R, the Austrian Breast and Clorectal Cancer Study Group (2004) Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer. Ann Surg 240: 306-312
35. Schoppmann SF, Birner P, Studer P, Breiteneder-Geleff S (2001) Lymphatic microvessel density and lymphovascular invasion assessed by anti-podoplanin immunostaining in human breast cancer. Anticancer Res 21: 2351-2356
36. Skobe M, Hawighorst T, Jackson DG, Prevo R, Janes L, Velasco P, Riccardi L, Alitalo K, Claffey K, Detmar M (2001) Induction of tumour lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nature Med 7: 192-198
37. Sleeman JP (2000) The lympn node as a bridgehead in the metastatic dissemination of tumors. Recent Results Cancer Res 157: 55-81
38. Stacker SA, Caesar C, Baldwin ME, Thornton G, Williams RA, Prevo R, Jackson DG, Nishikawa S, Kubo H, Achen MG (2001) VEGF-D promotes the metastatic spread of tumour cells via the lymphatics. Nature Med 7: 186-191
39. Straume O, Jackson DG, Akslen LA (2003) Independent prognostic impact of lymphatic vessel density and presence of low grade lymphangiogenesis in cutaneous melanoma. Clin Cancer Res 9: 150-155
40. Weidner N, Semple JP, Welch WR, Folkman J (1991) Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 324: 1-8
41. Wigle JT, Oliver G (1999) Prox 1 function is required for the development of the murine lymphatic system. Cell 98: 769-778
42. Williams CSM, Leek RD, Robson AM, Banerji S, Prevo R, Harris AL, Jackson DG (2003) Absence of lymphangiogenesis and intratumoural lymph vessels in human metastatic breast cancer. J Pathol 200: 195-206